Elevated PAF1-RAD52 axis confers chemoresistance to human cancers
Cell Reports · 2023-02 · 42 (2) · 112043
DOI: 10.1016/j.celrep.2023.112043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-02. Verfasst von Sanchita Rauth und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, NCI.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA.
- Fred and Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center at Omaha, Omaha, NE, USA.
- Department of Pathology and Microbiology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA.
- Department of Surgery, University of Nebraska Medical Center at Omaha, Omaha, NE, USA.
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA; Division of Oncology-Hematology, Department of Internal Medicine, VA Nebraska Western Iowa Health Care Sy…
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA; Fred and Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, Unive…
Förderung
- NCI NIH HHS
- National Institutes of Health
- NCI
- Nebraska Department of Health and Human Services
Zitieren
APA
Rauth, S., Ganguly, K., Atri, P., Parte, S., Nimmakayala, R. K., Varadharaj, V., Nallasamy, P., Vengoji, R., Ogunleye, A. O., Lakshmanan, I., Chirravuri, R., Bessho, M., Cox, J. L., Foster, J. M., Talmon, G. A., Bessho, T., Ganti, A. K., Batra, S. K., & Ponnusamy, M. P. (2023). Elevated PAF1-RAD52 axis confers chemoresistance to human cancers. Cell Reports, 42(2), 112043. https://doi.org/10.1016/j.celrep.2023.112043
Vancouver
Rauth S, Ganguly K, Atri P, Parte S, Nimmakayala RK, Varadharaj V, et al. Elevated PAF1-RAD52 axis confers chemoresistance to human cancers. Cell Reports. 2023;42(2):112043. doi:10.1016/j.celrep.2023.112043
BibTeX
@article{Rauth2023,
author = {Rauth, Sanchita and Ganguly, Koelina and Atri, Pranita and Parte, Seema and Nimmakayala, Rama Krishna and Varadharaj, Venkatesh and Nallasamy, Palanisamy and Vengoji, Raghupathy and Ogunleye, Ayoola O and Lakshmanan, Imayavaramban and Chirravuri, Ramakanth and Bessho, Mika and Cox, Jesse L and Foster, Jason M and Talmon, Geoffrey A and Bessho, Tadayoshi and Ganti, Apar Kishor and Batra, Surinder K and Ponnusamy, Moorthy P},
title = {Elevated PAF1-RAD52 axis confers chemoresistance to human cancers},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {2},
pages = {112043},
doi = {10.1016/j.celrep.2023.112043}
}
EUVIMED